Biodesix, Inc.

Biodesix, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Biodesix is a leading diagnostics solutions company, driven to improve clinical care and outcomes for patients. Biodesix Diagnostic Tests support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics.   Our culture: The foundation of Biodesix workplace culture is based on these operating principles: TEAM. IMPACT. EXCELLENCE. Based on anonymous team member surveys, Biodesix has been awarded Inc. Magazine's 2024 Best Workplaces and The Denver Post's 2025 Top Workplaces - https://topworkplaces.com/company/biodesix/   #bdsx #biodesix #lungcancer  #biopharma #lifesciences #diagnostics #proteomics #genomics #multiomics #radiomics #medicalAI #liquidbiopsy #digitaldiagnostics #oncology #lungcancer
Looking for a particular Biodesix, Inc. employee's phone or email?

Biodesix, Inc. Questions

News

Biodesix Announces Expanded Bio-Rad Laboratories - GlobeNewswire

Biodesix Announces Expanded Bio-Rad Laboratories GlobeNewswire

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 - Sahm

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 Sahm

Biodesix (NYSE: BDSX) to validate ddPLEX ESR1 assay; IVD filings and CLIA-CAP service - Stock Titan

Biodesix (NYSE: BDSX) to validate ddPLEX ESR1 assay; IVD filings and CLIA-CAP service Stock Titan

Biodesix Announces Second Quarter 2025 Results and Highlights - Yahoo Finance

Biodesix Announces Second Quarter 2025 Results and Highlights Yahoo Finance

1,000 Patients: Biodesix Presents Interim CLARIFY Results at CHEST, Study Plans Up to 4,000 - Stock Titan

1,000 Patients: Biodesix Presents Interim CLARIFY Results at CHEST, Study Plans Up to 4,000 Stock Titan

Biodesix Announces First Quarter 2025 Results and Highlights - Yahoo Finance

Biodesix Announces First Quarter 2025 Results and Highlights Yahoo Finance

3 October Lung Health Events: Biodesix Partners with APAPP, Go2 & American Lung Association in Colorado - Stock Titan

3 October Lung Health Events: Biodesix Partners with APAPP, Go2 & American Lung Association in Colorado Stock Titan

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting - GlobeNewswire

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting GlobeNewswire

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference - GlobeNewswire

Biodesix to Participate in Lake Street Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference GlobeNewswire

Biodesix Unveils October Lung Health Events in Colorado - GlobeNewswire

Biodesix Unveils October Lung Health Events in Colorado GlobeNewswire

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire

Biodesix Announces One-for-Twenty Reverse Stock Split - GlobeNewswire

Biodesix Announces One-for-Twenty Reverse Stock Split GlobeNewswire

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewswire

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics GlobeNewswire

Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire

Biodesix to Participate in Upcoming Investor Conferences GlobeNewswire

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS GlobeNewswire

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewswire

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award GlobeNewswire

Biodesix, Inc. Announces One-for-Twenty Reverse Stock Split Effective September 15, 2025 | BDSX Stock News - Quiver Quantitative

Biodesix, Inc. Announces One-for-Twenty Reverse Stock Split Effective September 15, 2025 | BDSX Stock News Quiver Quantitative

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - GlobeNewswire

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting GlobeNewswire

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - GlobeNewswire

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs GlobeNewswire

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Quiver Quantitative

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences Quiver Quantitative

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results GlobeNewswire

156M to 8M Shares: Biodesix Implements Major 1:20 Reverse Stock Split for Nasdaq Compliance - Stock Titan

156M to 8M Shares: Biodesix Implements Major 1:20 Reverse Stock Split for Nasdaq Compliance Stock Titan

Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing - Stock Titan

Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing Stock Titan

Breakthrough: Biodesix Creates Nation's First Lung Cancer Biomarker Training for Advanced Practice Providers - Stock Titan

Breakthrough: Biodesix Creates Nation's First Lung Cancer Biomarker Training for Advanced Practice Providers Stock Titan

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - GlobeNewswire

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study GlobeNewswire

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 Business Wire

Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces” - Business Wire

Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces” Business Wire

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management - Business Wire

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management Business Wire

Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT - Business Wire

Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT Business Wire

Biodesix Announces First Quarter 2023 Results and Highlights - FinancialContent

Biodesix Announces First Quarter 2023 Results and Highlights FinancialContent

Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights - FinancialContent

Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights FinancialContent

Biodesix Announces Third Quarter 2022 Results and Highlights - FinancialContent

Biodesix Announces Third Quarter 2022 Results and Highlights FinancialContent

Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million - FinancialContent

Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million FinancialContent

Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine - FinancialContent

Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine FinancialContent

Biodesix Announces Second Quarter 2022 Results and Highlights - FinancialContent

Biodesix Announces Second Quarter 2022 Results and Highlights FinancialContent

Top Biodesix, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant